基于脂质的疫苗佐剂递送技术新进展
本文综述了基于脂质的佐剂递送平台在疫苗开发中的应用。该类系统多为颗粒形式(乳剂、微/纳米颗粒、脂质体),可依据疫苗模态调整组成,促进疫苗向抗原呈递细胞递送,实现有效免疫应答、稳定性与安全性。
要点
- 脂质佐剂递送系统多为颗粒形式,如乳剂、微/纳米颗粒和脂质体。
- 其组成可调整以适配疫苗模态和递送需求。
- 可促进疫苗向抗原呈递细胞递送,支持核酸翻译与蛋白合成。
核心结论
- 基于脂质的颗粒系统是有前景且灵活的佐剂递送选择,可适配不同疫苗模态。
研究设计与样本
- 综述类:检索开源文献,分析基于脂质的疫苗佐剂递送平台的开发与评估。
主要发现
- 多数脂质疫苗佐剂递送系统为颗粒形式,包括乳剂、微/纳米颗粒和脂质体。
- 这些系统促进疫苗模态向抗原呈递细胞或其他靶细胞递送,支持核酸翻译和蛋白合成。
临床怎么用
- 可为疫苗产品开发中佐剂递送系统的选择与设计提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Historically infectious disease pandemics have caused health emergencies for humans as well as livestock on numerous occasions. In such situations and on a routine basis vaccination has emerged as an effective intervention for prevention and eradication of pathogenic infections. As the field of vaccine research has progressed, next generation vaccine platforms including protein subunits, recombinant proteins, nucleic acids (DNA, mRNA) and more have been discovered which rely on more complex adjuvants with capability to function as delivery carriers for the vaccine modalities helping achieve effective immune response, stability and safety. Lipids-based particulate systems are emerging, promising and flexible choices as adjuvant delivery systems because their makeup can be adjusted to suit the vaccine modality and the delivery needs. In this review open-source literature on development and evaluation of lipids-based delivery platforms which can also serve as vaccine adjuvants is studied. The survey reveals that the most lipids-based vaccine adjuvant delivery systems are particulate, such as emulsions, micro/nanoparticles, and liposomes facilitating the delivery of vaccine modalities to antigen-presenting cells (APCs) or other target cells enabling the nucleic acid translation and protein synthesis. This article is aimed at providing an overview of the lipids-based adjuvant delivery platforms with respect to the literature reports enlightening their applications in the field of vaccines which would serve as a reference for scientists undertaking vaccine product development.
引用
- Dhuri K, Ubhe A. Emerging lipids-based adjuvant delivery technologies for vaccines. Vaccine. 2026. PMID: 42097105. doi:10.1016/j.vaccine.2026.128662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。